← Back to headlines
Biogen and Alteogen Ink Licensing Deal for Injectable Products
Biogen and Alteogen have finalized a new licensing deal specifically for injectable products, further expanding their pharmaceutical portfolios.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Brookfield Structures $1.8 Billion Bond Deal to Fund $600 Million Dividend
42m ago
Nigeria Reports 4.43 Percent Economic Growth in Second Quarter
46m ago
Prediction Platform Kalshi Permanently Bans George Santos Over Insider Trading
49m ago
Pabst Brewing Offers 'No Questions Asked' Reward for Stolen Beer
59m ago